| 000 | 01673 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517042833.0 | ||
| 264 | 0 | _c20160509 | |
| 008 | 201605s 0 0 eng d | ||
| 022 | _a1879-114X | ||
| 024 | 7 |
_a10.1016/j.clinthera.2015.05.497 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSong, Yan | |
| 245 | 0 | 0 |
_aRelative Bioavailability of Apixaban Solution or Crushed Tablet Formulations Administered by Mouth or Nasogastric Tube in Healthy Subjects. _h[electronic resource] |
| 260 |
_bClinical therapeutics _cAug 2015 |
||
| 300 |
_a1703-12 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 |
_aAtrial Fibrillation _xblood |
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 | _aChemistry, Pharmaceutical |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 |
_aFactor Xa Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIntubation, Gastrointestinal |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPyrazoles _xadministration & dosage |
| 650 | 0 | 4 |
_aPyridones _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aWang, Xiaoli | |
| 700 | 1 | _aPerlstein, Itay | |
| 700 | 1 | _aWang, Jessie | |
| 700 | 1 | _aBadawy, Sherif | |
| 700 | 1 | _aFrost, Charles | |
| 700 | 1 | _aLaCreta, Frank | |
| 773 | 0 |
_tClinical therapeutics _gvol. 37 _gno. 8 _gp. 1703-12 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.clinthera.2015.05.497 _zAvailable from publisher's website |
| 999 |
_c25087845 _d25087845 |
||